BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24666396)

  • 1. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention.
    Deady S; Sharp L; Comber H
    Br J Dermatol; 2014 Aug; 171(2):324-31. PubMed ID: 24666396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
    Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
    Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.
    Hayes RC; Leonfellner S; Pilgrim W; Liu J; Keeling DN
    J Cutan Med Surg; 2007; 11(2):45-52. PubMed ID: 17374314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995.
    Plesko I; Severi G; Obsitníková A; Boyle P
    Neoplasma; 2000; 47(3):137-42. PubMed ID: 11043834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmelanoma skin cancer in an Irish population: an appraisal of risk factors.
    Healy E; Collins P; Barnes L
    Ir Med J; 1995; 88(2):58-9. PubMed ID: 7775148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996.
    Harris RB; Griffith K; Moon TE
    J Am Acad Dermatol; 2001 Oct; 45(4):528-36. PubMed ID: 11568742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
    Lewis KG; Weinstock MA
    Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple nonmelanoma skin cancer in an exposed Australian population.
    Raasch BA; Buettner PG
    Int J Dermatol; 2002 Oct; 41(10):652-8. PubMed ID: 12390187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population.
    Demers AA; Nugent Z; Mihalcioiu C; Wiseman MC; Kliewer EV
    J Am Acad Dermatol; 2005 Aug; 53(2):320-8. PubMed ID: 16021129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?
    Staples M; Marks R; Giles G
    Int J Cancer; 1998 Oct; 78(2):144-8. PubMed ID: 9754642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
    Katalinic A; Kunze U; Schäfer T
    Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
    Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH
    Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictions of skin cancer incidence in the Netherlands up to 2015.
    de Vries E; van de Poll-Franse LV; Louwman WJ; de Gruijl FR; Coebergh JW
    Br J Dermatol; 2005 Mar; 152(3):481-8. PubMed ID: 15787817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.
    Nugent Z; Demers AA; Wiseman MC; Mihalcioiu C; Kliewer EV
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2584-90. PubMed ID: 16284382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin cancer trends in northern Jordan.
    Omari AK; Khammash MR; Matalka I
    Int J Dermatol; 2006 Apr; 45(4):384-8. PubMed ID: 16650163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance.
    Kaldor J; Shugg D; Young B; Dwyer T; Wang YG
    Int J Cancer; 1993 Apr; 53(6):886-91. PubMed ID: 8473047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of non-melanoma skin cancer: who, why and what can we do about it.
    Marks R
    J Dermatol; 1995 Nov; 22(11):853-7. PubMed ID: 8557858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.